Marker Therapeutics Inc (MRKR)

[microcapbiotech]

Howdy Phantom, By optimize the therapy for PC, I guessing that because Peter said they can add more PC specific antigens.

I'm also guessing that the FDA won't let them add those more PC specific antigens to the current trial.

It would kind of suck if they had to start all over.

It's damned if you do and damned if you don't.

Peter had mentioned that they already did the pre-clinical work to add the more PC antigens.

Was that AFTER they started the trial?
I'm guessing yes, because then why wouldn't they have added them if all the work was already done?

I'm really perplexed on this because I don't know if the market will like:

"hey, we got great PC news … but it doesn't matter because we are starting PC all over.